2nd iPSC Consortia Agenda

2nd iPSC Consortia Workshop

December 15, 2010
Hyatt Regency
Bethesda, Maryland
Workshop Participant List Executive Summary

Agenda

9:00 a.m.

Welcome and Introduction of Workshop Goals
Story Landis

9:10 a.m.

2010 Consortia Accomplishments
Margaret Sutherland

9:30 a.m.

PD iPSC Consortium
Ole Isacson
Ted Dawson, Jian Feng, Dimitri Krainc, Virginia Lee, Karen Marder, Serge Przedborski, Owen Ross, Jim Surmeier, John Trojanowski, Zbigniew Wszolek

10:45 a.m.

BREAK

11:00 a.m.

ALS iPSC Consortium
Jeffrey Rothstein
Merit Cudkowicz, Kevin Eggan, Chris Henderson, Thomas Maniatis, Berta Strulovici

12:15 p.m.

Working Lunch

12:45 p.m.

Coriell Fibroblast and iPSC Cell Banking
Katrina Gwinn

1:00 p.m.

Office of Technology Transfer—Secondary Distribution
Laurie Arrants

1:15 p.m.

HD iPSC Consortium
Leslie Thompson
Nicholas Allen, Elena Cattaneo, Steve Finkbeiner, Jim Gusella, Paul Kemp, Kwang-Soo Kim, Marcy MacDonald, Marco Onorati, Chris Ross, Clive Svendsen

2:30 p.m.

The iPSC Report Card
Chris Henderson

2:50 p.m.

BREAK

3:10 p.m.

Industry Perspective—iPSC Lines for Compound Screening—Opportunities and Challenges

GSK, Roxanne Duan
Lundbeck, Kenneth Vielsted Christensen
Pfizer, John Dunlop
Vertex, Branka Mitrovic

4:00 p.m.

Voluntary Priorities for iPSC Lines in Current and Future Funding Opportunities

ALS Association (ALSA), Lucie Bruijn
Project A.L.S., Valerie Estess
Robert Packard Center for ALS Research, Jeffrey Rothstein
Hereditary Disease Foundation (HDF), Nancy Wexler
CHDI Foundation, Inc., Jamshid Arjomand
Michael J. Fox Foundation for Parkinson’s Research (MJFF), Brian Fiske
Parkinson’s Disease Foundation (PDF), James Beck

4:35 p.m.

Future Priorities, Milestones, and Cost-Effective Research
Margaret Sutherland
David Owens

Closing Remarks
All participants

5:00 p.m.

Close of Meeting

Last updated March 20, 2013